MEGAN KELSEY: Open Payments
NPI 1881374023 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,360 in 177 payments from 19 companies in 2025. Trend: 2023 $1,022 · 2024 $3,045 · 2025 $3,360
Food & beverage: $3,352Education: $8
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $604 |
| Janssen Pharmaceuticals, Inc | 37 | $414 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $343 |
| E.R. Squibb & Sons, L.L.C. | 14 | $316 |
| Otsuka America Pharmaceutical, Inc. | 15 | $268 |
| Teva Pharmaceuticals USA, Inc. | 10 | $253 |
| Axsome Therapeutics, Inc. | 8 | $204 |
| Neurocrine BioSciences, Inc. | 4 | $179 |
| Supernus Pharmaceuticals, Inc. | 11 | $146 |
| Lundbeck LLC | 9 | $136 |
Products named: VRAYLAR, REXULTI, CAPLYTA, COBENFY, SPRAVATO, AUSTEDO XR, Auvelity, INGREZZA.
Industry payments across TX — which companies pay providers there.
